The utilisation of structural descriptors to predict metabolic constants of xenobiotics in mammals.

[1]  Jia He,et al.  Investigation on the relationship between bioconcentration factor and distribution coefficient based on class-based compounds: The factors that affect bioconcentration. , 2014, Environmental toxicology and pharmacology.

[2]  M. Huijbregts,et al.  Mechanistically-based QSARs to Describe Metabolic Constants in Mammals , 2014, Alternatives to laboratory animals : ATLA.

[3]  Paola Gramatica,et al.  Metabolic biotransformation half-lives in fish: QSAR modeling and consensus analysis. , 2014, The Science of the total environment.

[4]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[5]  M. Huijbregts,et al.  Compound lipophilicity as a descriptor to predict binding affinity (1/K(m)) in mammals. , 2012, Environmental science & technology.

[6]  Igor V. Tetko,et al.  Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information , 2011, J. Comput. Aided Mol. Des..

[7]  Jason A. Morrill,et al.  Development of quantitative structure-activity relationships for explanatory modeling of fast reacting (meth)acrylate monomers bearing novel functionality. , 2011, Journal of molecular graphics & modelling.

[8]  Antje Chang,et al.  BRENDA, the enzyme information system in 2011 , 2010, Nucleic Acids Res..

[9]  Sanford Weisberg,et al.  An R Companion to Applied Regression , 2010 .

[10]  S. Balaz,et al.  Modeling Kinetics of Subcellular Disposition of Chemicals , 2009, Chemical reviews.

[11]  Roberto Todeschini,et al.  Molecular descriptors for chemoinformatics , 2009 .

[12]  Ivonne M C M Rietjens,et al.  Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity. , 2008, Chemical research in toxicology.

[13]  Roberto Todeschini,et al.  Descriptors from Molecular Geometry , 2008 .

[14]  John C Lipscomb,et al.  In vitro measurements of metabolism for application in pharmacokinetic modeling. , 2008, Pharmacology & therapeutics.

[15]  Paola Gramatica,et al.  QSAR study of selective ligands for the thyroid hormone receptor beta. , 2007, Bioorganic & medicinal chemistry.

[16]  C. Steinbeck,et al.  Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.

[17]  Manuela Pavan,et al.  DRAGON SOFTWARE: AN EASY APPROACH TO MOLECULAR DESCRIPTOR CALCULATIONS , 2006 .

[18]  David E. Williams,et al.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. , 2005, Pharmacology & therapeutics.

[19]  Ian H. Witten,et al.  Weka-A Machine Learning Workbench for Data Mining , 2005, Data Mining and Knowledge Discovery Handbook.

[20]  Maurice Dickins,et al.  Compound lipophilicity for substrate binding to human P450s in drug metabolism. , 2004, Drug discovery today.

[21]  P. Eddershaw,et al.  Phase I Metabolism , 2004 .

[22]  Corwin Hansch,et al.  QSAR of Cytochrome P450 , 2004, Drug metabolism reviews.

[23]  David F. V. Lewis,et al.  Quantitative structure–activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s , 2004, InflammoPharmacology.

[24]  L. Eriksson,et al.  Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. , 2003, Environmental Health Perspectives.

[25]  M. Cronin,et al.  Pitfalls in QSAR , 2003 .

[26]  Igor V. Tetko,et al.  Application of Associative Neural Networks for Prediction of Lipophilicity in ALOGPS 2.1 Program , 2002, J. Chem. Inf. Comput. Sci..

[27]  Bas J Blaauboer,et al.  The applicability of in vitro-derived data in hazard identification and characterisation of chemicals. , 2002, Environmental toxicology and pharmacology.

[28]  D. Lewis,et al.  Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s. , 2002, Toxicology.

[29]  R. Leardi.  Genetic algorithms in chemometrics and chemistry: a review , 2001 .

[30]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[31]  V. Vasiliou,et al.  Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. , 2000, Chemico-biological interactions.

[32]  Patrizia Crivori,et al.  The influence of lipophilicity on the pharmacokinetic behavior of drugs: Concepts and examples , 2000 .

[33]  D. F. Lewis.  Frontier orbitals in chemical and biological activity: quantitative relationships and mechanistic implications. , 1999, Drug metabolism reviews.

[34]  C. Waller,et al.  Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[35]  E. Hodgson,et al.  Pesticide-metabolizing enzymes. , 1995, Toxicology letters.

[36]  Lemont B. Kier,et al.  Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information , 1995, J. Chem. Inf. Comput. Sci..

[37]  D. Meent,et al.  Transport, Accumulation and Transformation Processes , 1995 .

[38]  F. Guengerich,et al.  Interpretations of cytochrome P450 mechanisms from kinetic studies. , 1995, Biochimie.

[39]  Jorge Gálvez,et al.  Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..

[40]  C. Hansch,et al.  Quantitative structure-activity relationships of cytochrome P-450. , 1993, Drug metabolism reviews.

[41]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..